Trial Profile
Study of effect of NOACs in the form of rivaroxaban in patients with left ventricular thrombi
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Sep 2018
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Thrombosis
- Focus Adverse reactions; Therapeutic Use
- 19 Sep 2018 New trial record
- 29 Aug 2018 Results presented at the ESC Congress 2018: Annual Congress of the European Society of Cardiology